Kevan C. Herold, M.D.

Professor of Immunobiology
Yale University

Poster(s):

• Tu203 - Epstein-Barr Virus Seropositivity Modulates the Immune Response to T Cell-Targeted Therapies in Type 1 Diabetes.
  Tuesday, June 24, 2025

  6:15pm - 7:30am East Coast USA Time